Legato Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Legato Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$821K	Buy	8,557 +1,635	+24%	+$168K	0.07%	411
2026 Q1	$756K	Hold	6,922	–	–	0.07%	377
2025 Q4	$561K	Sell	6,922 -6,597	-49%	-$568K	0.05%	513
2025 Q3	$1.18M	Hold	13,519	–	–	0.13%	249
2025 Q2	$1.12M	Sell	13,519 -7,898	-37%	-$660K	0.13%	244
2025 Q1	$1.8M	Sell	21,417 -1,761	-8%	-$164K	0.24%	119
2024 Q4	$2.14M	Buy	23,178 +476	+2%	+$45.8K	0.28%	85
2024 Q3	$2.11M	Sell	22,702 -2,634	-10%	-$228K	0.26%	113
2024 Q2	$2.08M	Buy	25,336 +6,028	+31%	+$443K	0.28%	97
2024 Q1	$1.28M	Hold	19,308	–	–	0.15%	221
2023 Q4	$1.1M	Hold	19,308	–	–	0.14%	236
2023 Q3	$1.05M	Sell	19,308 -7,760	-29%	-$460K	0.15%	231
2023 Q2	$1.82M	Buy	27,068 +1,281	+5%	+$78.1K	0.25%	129
2023 Q1	$1.33M	Hold	25,787	–	–	0.24%	136
2022 Q4	$1.19M	Buy	+25,787	New	+$1.21M	0.23%	145

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Legato Capital Management's LMAT Position: Q2 2026 in Review

Legato Capital Management increased its LeMaitre Vascular (LMAT) stake by 24% in Q2 2026, buying an estimated $168K and bringing the position to 8,557 shares worth $821K. The position accounts for 0.07% of the portfolio, ranked #411.

Legato Capital Management first reported a position in LMAT in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.14M in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Legato Capital Management held 8,557 shares of LeMaitre Vascular worth $821K as of Q2 2026.
Legato Capital Management bought 1,635 LeMaitre Vascular shares in Q2 2026, an estimated $168K.
LeMaitre Vascular made up 0.07% of Legato Capital Management's portfolio in Q2 2026, its #411 holding.
Legato Capital Management first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 15 quarters since.
Legato Capital Management's LeMaitre Vascular position peaked at $2.14M in Q4 2024.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.